By Dawood Fakhir ( January 9, 2023, 3:37 PM GMT) -- French pharmaceutical company Ipsen on Monday said it has agreed to acquire biotechnology company Albireo Pharma for approximately $952 million in a deal guided by Paul Weiss Rifkind Wharton & Garrison LLP, Orrick Herrington & Sutcliffe LLP, and Mintz Levin Cohn Ferris Glovsky and Popeo PC....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.